BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

NCT04150614 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Nausea With Vomiting Chemotherapy-Induced

Interventions

DRUG: Granisetron Transdermal Patch
DRUG: Intravenous Dexamethasone
DRUG: Ondansetron

Sponsor

University of Illinois at Chicago